Evidence map›Paper›PMID 37080632›Full record

ArticleBMJ case reports2023

Amyloid transthyretin cardiac amyloidosis with different manifestations, test findings and types.

Jeffery Budweg, Mohammad Al-Ani, Yazan Assaf, Alex Parker, Juan Aranda

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jeffery BudwegMedicine, University of Florida, Gainesville, Florida, USA jeffery.budweg@medicine.ufl.edu.ORCID http://orcid.org/0000-0001-7044-9979
Mohammad Al-AniMedicine, Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida, USA.ORCID http://orcid.org/0000-0002-7220-1114
Yazan AssafMedicine, University of Florida, Gainesville, Florida, USA.ORCID http://orcid.org/0000-0002-0106-1118
Alex ParkerMedicine, Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida, USA.
Juan ArandaMedicine, Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyloid transthyretin amyloidosis usually presents with cardiac amyloidosis manifestations, most commonly with a heart failure syndrome. The history and physical examination offer clues of other cardiac and extracardiac manifestations. Taking a detailed history is essential in elucidating pertinent family and medical history that may increase suspicion for amyloidosis. Further, certain findings on electrocardiogram and imaging should raise suspicion and trigger further workup that can confirm the diagnosis, since treatment is evolving.

Indexed as

Amyloid Neuropathies, FamilialCardiomyopathiesHeart FailureDiagnostic ImagingElectrocardiographyHumansPrealbuminPrealbuminCardiovascular systemHeart failure

Identifiers

PMID37080632
PMCPMC10124201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.